• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃化生的内镜监测:一项回顾性队列研究。

Endoscopic Surveillance of Gastric Intestinal Metaplasia: A Retrospective Cohort Study.

作者信息

Yoon Ji Yoon, Katcher Erik, Cohen Ella, Ward Stephen C, Rouphael Carol, Itzkowitz Steven H, Wang Christina P, Kim Michelle K, Shah Shailja C

机构信息

Departments of Gastroenterology.

Sackler School of Medicine at Tel Aviv University, Tel Aviv, Israel.

出版信息

J Clin Gastroenterol. 2024 Jul 17. doi: 10.1097/MCG.0000000000002039.

DOI:10.1097/MCG.0000000000002039
PMID:39042489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11739429/
Abstract

BACKGROUND

Gastric intestinal metaplasia (GIM) is a precancerous condition. Limited data exist on real-world clinical practice relative to guidelines.

AIM

The aim of this study was to evaluate adherence to GIM risk stratification and identify factors associated with follow-up endoscopy.

MATERIALS AND METHODS

We conducted manual chart review of patients with histologically confirmed GIM at an urban, tertiary medical center were identified retrospectively and details of their demographics, Helicobacter pylori, biopsy protocol, endoscopic/histologic findings, and postendoscopy follow-up were recorded. Multivariable logistic regression was used to identify factors independently associated with follow-up endoscopy.

RESULTS

Among 253 patients, 59% were female, 37% non-Hispanic White (NHW), 26% Hispanic, 16% non-Hispanic Black (NHB). The median age at index endoscopy was 63.4 years (IQR: 55.9 to 70.0), with median follow-up of 65.1 months (IQR: 44.0 to 72.3). H. pylori was detected in 21.6% patients at index EGD. GIM extent and subtype data were frequently missing (22.9% and 32.8%, respectively). Based on available data, 26% had corpus-extended GIM and 28% had incomplete/mixed-type GIM. Compared with NHW, Hispanic patients had higher odds of follow-up EGD (OR=2.48, 95% CI: 1.23-5.01), while NHB patients had 59% lower odds of follow-up EGD (OR=0.41, 95% CI: 0.18-0.96). Corpus-extended GIM versus limited GIM (OR=2.27, 95% CI: 1.13-4.59) was associated with follow-up EGD, but GIM subtype and family history of gastric cancer were not.

CONCLUSIONS

We observed suboptimal risk stratification among patients with GIM and notable race and ethnic disparities with respect to endoscopic surveillance. Targeted interventions are needed to improve practice patterns and mitigate observed disparities.

摘要

背景

胃黏膜肠化生(GIM)是一种癌前状态。关于实际临床实践与指南相关的数据有限。

目的

本研究的目的是评估对GIM风险分层的依从性,并确定与随访内镜检查相关的因素。

材料与方法

我们对一家城市三级医疗中心经组织学确诊为GIM的患者进行了人工病历审查,回顾性确定患者,并记录其人口统计学、幽门螺杆菌、活检方案、内镜/组织学检查结果以及内镜检查后随访的详细信息。采用多变量逻辑回归分析确定与随访内镜检查独立相关的因素。

结果

253例患者中,59%为女性,37%为非西班牙裔白人(NHW),26%为西班牙裔,16%为非西班牙裔黑人(NHB)。首次内镜检查时的中位年龄为63.4岁(四分位间距:55.9至70.0岁),中位随访时间为65.1个月(四分位间距:44.0至72.3个月)。首次胃镜检查时,21.6%的患者检测到幽门螺杆菌。GIM范围和亚型数据经常缺失(分别为22.9%和32.8%)。根据现有数据,26%的患者有胃体扩展型GIM,28%的患者有不完全/混合型GIM。与NHW相比,西班牙裔患者进行随访胃镜检查的几率更高(比值比=2.48,95%置信区间:1.23 - 5.01),而NHB患者进行随访胃镜检查的几率低59%(比值比=0.41,95%置信区间:0.18 - 0.96)。胃体扩展型GIM与局限性GIM相比(比值比=2.27,95%置信区间:1.13 - 4.59)与随访胃镜检查相关,但GIM亚型和胃癌家族史则不然。

结论

我们观察到GIM患者的风险分层欠佳,且在内镜监测方面存在显著的种族和族裔差异。需要有针对性的干预措施来改善实践模式并减轻观察到的差异。

相似文献

1
Endoscopic Surveillance of Gastric Intestinal Metaplasia: A Retrospective Cohort Study.胃化生的内镜监测:一项回顾性队列研究。
J Clin Gastroenterol. 2024 Jul 17. doi: 10.1097/MCG.0000000000002039.
2
AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review.美国胃癌高危个体筛查与监测的美国胃肠病学会临床实践更新:专家综述
Gastroenterology. 2025 Feb;168(2):405-416.e1. doi: 10.1053/j.gastro.2024.11.001. Epub 2024 Dec 23.
3
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines.通向胃黏膜肠上皮化生患者管理的全球统一方法之路:当前指南综述。
Gut. 2024 Sep 9;73(10):1607-1617. doi: 10.1136/gutjnl-2024-333029.
4
Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.在上消化道内镜活检中胃肠化生的患病率、危险因素和监测模式。
Gastrointest Endosc. 2020 Jan;91(1):70-77.e1. doi: 10.1016/j.gie.2019.07.038. Epub 2019 Aug 16.
5
Ethnicity Is an Important Consideration in Screening for Gastric Intestinal Metaplasia.种族是筛查胃肠化生的重要考虑因素。
Dig Dis Sci. 2022 Sep;67(9):4509-4517. doi: 10.1007/s10620-021-07326-2. Epub 2022 Jan 4.
6
The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.哥伦比亚化学预防试验:胃癌前病变队列患者 20 年随访。
Gastroenterology. 2021 Mar;160(4):1106-1117.e3. doi: 10.1053/j.gastro.2020.11.017. Epub 2020 Nov 18.
7
Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution.提高美国学术医疗机构胃肠病学家遵循胃黏膜肠上皮化生临床实践指南的能力。
J Clin Gastroenterol. 2024;58(5):432-439. doi: 10.1097/MCG.0000000000001890. Epub 2023 Jul 13.
8
Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome.林奇综合征患者接受监测性上消化道内镜检查时胃肠上皮化生和幽门螺杆菌的检出率较低。
Fam Cancer. 2024 Mar;23(1):23-27. doi: 10.1007/s10689-023-00354-z. Epub 2024 Jan 31.
9
Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025.胃上皮癌前病变和早期肿瘤的管理(MAPS III):欧洲胃肠内镜学会(ESGE)、欧洲幽门螺杆菌与微生物群研究组(EHMSG)及欧洲病理学会(ESP)2025年指南更新
Endoscopy. 2025 May;57(5):504-554. doi: 10.1055/a-2529-5025. Epub 2025 Mar 20.
10
Clinical epidemiology and outcomes of patients with gastric intestinal metaplasia in the Los Angeles County System.洛杉矶县系统中胃肠化生患者的临床流行病学和结局。
BMC Gastroenterol. 2023 May 19;23(1):165. doi: 10.1186/s12876-023-02797-1.

本文引用的文献

1
Demographic Comparison of the Burden of Endoscopically Screenable Cancers in the United States.美国可通过内镜筛查的癌症负担的人口统计学比较。
Gastro Hep Adv. 2024 Jan 18;3(4):482-490. doi: 10.1016/j.gastha.2024.01.005. eCollection 2024.
2
Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates.基于癌症干预和监测建模网络估计的乳腺癌筛查策略的结果。
Radiology. 2024 Feb;310(2):e232658. doi: 10.1148/radiol.232658.
3
The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally Detected Gastric Intestinal Metaplasia: A Microsimulation Analysis.偶然发现的胃肠化生监测的临床影响和成本效益:微观模拟分析。
Clin Gastroenterol Hepatol. 2024 Jan;22(1):51-61. doi: 10.1016/j.cgh.2023.05.028. Epub 2023 Jun 9.
4
Clinical epidemiology and outcomes of patients with gastric intestinal metaplasia in the Los Angeles County System.洛杉矶县系统中胃肠化生患者的临床流行病学和结局。
BMC Gastroenterol. 2023 May 19;23(1):165. doi: 10.1186/s12876-023-02797-1.
5
Index diagnoses of gastric intestinal metaplasia in the United States: patient characteristics, endoscopic findings, and clinical practice patterns at a large tertiary care center.美国胃化生的索引诊断:大型三级医疗中心的患者特征、内镜检查结果及临床实践模式
Therap Adv Gastroenterol. 2022 Sep 3;15:17562848221117640. doi: 10.1177/17562848221117640. eCollection 2022.
6
Heightened Risk for Gastric Cancer Among Immigrant Populations in New York State From High-Incidence Countries.纽约州来自高发病率国家的移民人群患胃癌风险增加。
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2673-2675.e3. doi: 10.1016/j.cgh.2022.08.008. Epub 2022 Aug 19.
7
Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP).胃肠化生严重程度预测胃癌风险:一项前瞻性多中心队列研究(GCEP)。
Gut. 2022 May;71(5):854-863. doi: 10.1136/gutjnl-2021-324057. Epub 2021 May 11.
8
Racial Disparities in Adherence to Quality Indicators in Barrett's Esophagus: An Analysis Using the GIQuIC National Benchmarking Registry.种族差异对巴雷特食管质量指标的依从性:使用 GIQuIC 国家基准注册分析。
Am J Gastroenterol. 2021 Jun 1;116(6):1201-1210. doi: 10.14309/ajg.0000000000001230.
9
Gastric cancer: a neglected threat to racial and ethnic minorities in the USA.胃癌:对美国少数族裔的一种被忽视的威胁。
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):266-267. doi: 10.1016/S2468-1253(21)00064-9.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.